These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6955228)

  • 1. [Safety in the distribution of pharmaceuticals].
    Langenfelder D
    Dent Echo (Heidelb); 1982 Mar; 52(2):43-6. PubMed ID: 6955228
    [No Abstract]   [Full Text] [Related]  

  • 2. Vulnerable points in the U.S. drug-distribution system.
    Shepherd M
    Manag Care; 2004 Mar; 13(3 Suppl):25-9. PubMed ID: 15074167
    [No Abstract]   [Full Text] [Related]  

  • 3. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption.
    Poser S
    Food Drug Law J; 2007; 62(4):653-94. PubMed ID: 18557225
    [No Abstract]   [Full Text] [Related]  

  • 4. Institute of Medicine's new drug safety report: implications for Canada.
    Cassels A
    CMAJ; 2006 Dec; 175(12):1515-6. PubMed ID: 17146086
    [No Abstract]   [Full Text] [Related]  

  • 5. Patient Safety Alert. Pfizer to bar code drugs to reduce dispensing errors.
    Hosp Peer Rev; 2003 Apr; 28(4):suppl 3-4. PubMed ID: 12683098
    [No Abstract]   [Full Text] [Related]  

  • 6. District Court approves hospital resale of pharmaceuticals, "No Solicitation" policy.
    Miles JJ
    Health Law Vigil; 1986 Oct; 9(20):13-4. PubMed ID: 10317776
    [No Abstract]   [Full Text] [Related]  

  • 7. The off-label use of medication in South Africa--what about some information for medical practitioners?
    Jansen RM
    S Afr Med J; 2009 Jun; 99(6):438-9. PubMed ID: 19736843
    [No Abstract]   [Full Text] [Related]  

  • 8. Illegal importation of pharmaceuticals: implications for community pharmacy and public health.
    Fuller C
    Manag Care; 2004 Mar; 13(3 Suppl):34-5. PubMed ID: 15074169
    [No Abstract]   [Full Text] [Related]  

  • 9. Where does drug importation stand now?
    Guglielmo WJ
    Med Econ; 2005 Mar; 82(6):42, 44, 46. PubMed ID: 15869085
    [No Abstract]   [Full Text] [Related]  

  • 10. The federal preemption debate in pharmaceutical labeling product liability actions.
    Gross JM; Curry JA
    Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866
    [No Abstract]   [Full Text] [Related]  

  • 11. New countermeasures considered as drug counterfeiting grows.
    Schubert C
    Nat Med; 2008 Jul; 14(7):700. PubMed ID: 18607355
    [No Abstract]   [Full Text] [Related]  

  • 12. [Distribution relations in the pharmaceutical trade and stock economy].
    Mitlöhner A
    Pharm Prax; 1967; 3():65-8. PubMed ID: 5599675
    [No Abstract]   [Full Text] [Related]  

  • 13. Perspectives. Internet likely to open brave new world in global pharmaceuticals trade.
    Otrompke J
    Med Health; 2000 Oct; 54(39):suppl 1-4. PubMed ID: 11184825
    [No Abstract]   [Full Text] [Related]  

  • 14. TRIPS, pharmaceuticals, developing countries, and the Doha "solution".
    Sykes AO
    Chic J Int Law; 2002; 3(1):47-68. PubMed ID: 15709299
    [No Abstract]   [Full Text] [Related]  

  • 15. The learned intermediary doctrine: past, present and future.
    Alsobrook HB
    Leg Med; 1994; ():269-80. PubMed ID: 7830482
    [No Abstract]   [Full Text] [Related]  

  • 16. The case for preemption of prescription drug failure-to-warn claims.
    Kim CH
    Food Drug Law J; 2007; 62(2):399-422. PubMed ID: 17632969
    [No Abstract]   [Full Text] [Related]  

  • 17. Biotech products pose distribution challenges.
    Szeinbach SL; Gillenwater EL
    Am Pharm; 1994 Mar; NS34(3):19-20. PubMed ID: 8192094
    [No Abstract]   [Full Text] [Related]  

  • 18. [Planning and contract directions in the distribution and consumption of drugs].
    Ausborn D
    Pharm Prax; 1969; 4():90-2. PubMed ID: 5792750
    [No Abstract]   [Full Text] [Related]  

  • 19. Substandard and counterfeit medicines.
    Rassool GH
    J Adv Nurs; 2004 May; 46(3):338-9. PubMed ID: 15119344
    [No Abstract]   [Full Text] [Related]  

  • 20. [Liability for drug-related damage by the pharmaceutical industry and the physician].
    Dahse G
    Beitr Gerichtl Med; 1982; 40():21-2. PubMed ID: 7165639
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.